Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has ...

A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.

Recent events indicate that a poorly coordinated process of review by different government agencies may lead to additional delays in the initiation of human testing of gene-therapy protocols.

The Cancer Cell and Gene ... Therapy, which is a tri-institutional collaboration among Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital. Under the aegis of these ...

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

With this information in hand, researchers who are developing a gene therapy to treat a muscle condition, for instance, could use the atlas to identify AAV vectors that preferentially target the ...

and efficacy of cell-based products Don't missed the opportunity to engage in a special panel discussion as industry experts discuss the present and future direction of the cell and gene therapy ...

Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic ...

By studying basic biology in our cells ... Center for Virology and Vaccine Research at BIDMC, member of the Gene and Cell Therapy Institute at Mass General Brigham, and member of the faculty ...